The Effect of LDL557 on Improving Degenerative Arthritis in the Elderly
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 45 and 80 years old?
Source: NCT06658821, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Chung Shan Medical University
- Trial code
- NCT06658821
- Record updated
- 17 August 2026
- Original description
This project is to conduct a clinical trial of SYNBIO TECH INC.'s LDL557 capsule for joint protection. To understand the improvement of joint discomfort and inflammation after supplementation, we hope to provide an updated choice for modern people's joint protection.Read full original descriptionShow less
This project is to conduct a clinical trial of SYNBIO TECH INC.'s LDL557 capsule for joint protection. To understand the improvement of joint discomfort and inflammation after supplementation, we hope to provide an updated choice for modern people's joint protection.
Inclusion: BMI 18-40 kg/m2; Those with early stage degenerative arthritis symptoms judged by X-ray to be Kellgren-Lawrence Grading Scale level 1 or 2, and the physician determines that long-term treatment is not needed or WOMAC score>2.0 or WOMAC total scale score>12 or VAS score ≦6.
Exclusion: Those who use non-steroidal anti-inflammatory analgesics and those who have had joint surgery; diabetes; Those with cardiovascular and cerebrovascular, rheumatoid or mental diseases; Patients undergoing cancer treatment; Smoking; alcoholism; breastfeeding women and pregnant women; Those consuming dietary supplements were excluded; Rheumatoid arthritis; Those who have had joint injections within 6 months.